Have We Changed the Outcome in Membranous Nephropathy? A Propensity Study on the Role of Immunosuppressive Therapy | Zendy

Daniel C. Cattran | Zendy; Heather N. Reich | Zendy; S. Joseph Kim | Zendy; Stéphan Troyanov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Have We Changed the Outcome in Membranous Nephropathy? A Propensity Study on the Role of Immunosuppressive Therapy

Author(s) -

Daniel C. Cattran,

Heather N. Reich,

S. Joseph Kim,

Stéphan Troyanov

Publication year - 2011

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.11001210

Subject(s) - medicine , proteinuria , propensity score matching , membranous nephropathy , renal function , nephropathy , kidney , endocrinology , diabetes mellitus

The long-term effect of immunosuppressive therapy (IS) on kidney survival in idiopathic membranous nephropathy (MGN) is debated. The introduction of renin angiotensin blockade, rigorous BP control, and the increasing age at presentation of patients with MGN adds further uncertainty. Given these important changes, we sought to determine whether implementation of IS has altered outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research